These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Polymorphisms in genes encoding acetylsalicylic acid metabolizing enzymes are unrelated to upper gastrointestinal health in cardiovascular patients on acetylsalicylic acid. van Oijen MG; Huybers S; Peters WH; Drenth JP; Laheij RJ; Verheugt FW; Jansen JB Br J Clin Pharmacol; 2005 Dec; 60(6):623-8. PubMed ID: 16305586 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of acetylsalicylic acid and its metabolites at low doses: a compartmental modeling. Dubovská D; Piotrovskij VK; Gajdos M; Krivosíková Z; Spustová V; Trnovec T Methods Find Exp Clin Pharmacol; 1995; 17(1):67-77. PubMed ID: 7623523 [TBL] [Abstract][Full Text] [Related]
6. Genetic variants of UGT1A6 influence risk of colorectal adenoma recurrence. Hubner RA; Muir KR; Liu JF; Logan RF; Grainge M; Armitage N; Shepherd V; Popat S; Houlston RS; Clin Cancer Res; 2006 Nov; 12(21):6585-9. PubMed ID: 17085674 [TBL] [Abstract][Full Text] [Related]
7. Analytical determination and pharmacokinetics of major metabolites of carbasalate calcium in broilers following oral administration. Wang X; Huang LL; Chen DM; Ihsan A; Yuan ZH J Vet Pharmacol Ther; 2011 Aug; 34(4):410-6. PubMed ID: 21091728 [TBL] [Abstract][Full Text] [Related]
8. Rapid and sensitive determination of acetylsalicylic acid and salicylic acid in plasma using liquid chromatography-tandem mass spectrometry: application to pharmacokinetic study. Xu X; Koetzner L; Boulet J; Maselli H; Beyenhof J; Grover G Biomed Chromatogr; 2009 Sep; 23(9):973-9. PubMed ID: 19358313 [TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms in UDP-glucuronosyltransferase 1A6 are not associated with NSAIDs-related peptic ulcer haemorrhage. van Oijen MG; Koetsier MI; Laheij RJ; Roelofs HM; te Morsche RH; Peters WH; Verheugt FW; Jansen JB; Drenth JP Drug Metab Lett; 2009 Aug; 3(3):199-204. PubMed ID: 19799547 [TBL] [Abstract][Full Text] [Related]
10. Determinants of aspirin metabolism in healthy men and women: effects of dietary inducers of UDP-glucuronosyltransferases. Navarro SL; Saracino MR; Makar KW; Thomas SS; Li L; Zheng Y; Levy L; Schwarz Y; Bigler J; Potter JD; Lampe JW J Nutrigenet Nutrigenomics; 2011; 4(2):110-8. PubMed ID: 21625173 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of propofol and extrahepatic UGT1A6 gene expression in anhepatic rats. Gu J; Lu K; Xia P; Tang M; Dai Q; Ma D; Tao G Pharmacology; 2009; 84(4):219-26. PubMed ID: 19752585 [TBL] [Abstract][Full Text] [Related]
12. UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: I. Identification of polymorphisms in the 5'-regulatory and exon 1 regions, and association with human liver UGT1A6 gene expression and glucuronidation. Krishnaswamy S; Hao Q; Al-Rohaimi A; Hesse LM; von Moltke LL; Greenblatt DJ; Court MH J Pharmacol Exp Ther; 2005 Jun; 313(3):1331-9. PubMed ID: 15761114 [TBL] [Abstract][Full Text] [Related]
14. UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: II. Functional impact of the three most common nonsynonymous UGT1A6 polymorphisms (S7A, T181A, and R184S). Krishnaswamy S; Hao Q; Al-Rohaimi A; Hesse LM; von Moltke LL; Greenblatt DJ; Court MH J Pharmacol Exp Ther; 2005 Jun; 313(3):1340-6. PubMed ID: 15761113 [TBL] [Abstract][Full Text] [Related]
15. Effects of nocloprost clathrate on absorption of acetylsalicylic acid. Siegmund W; Zschiesche M; Franke G; Amon I Int J Clin Pharmacol Ther; 1994 Jan; 32(1):51-7. PubMed ID: 8199752 [TBL] [Abstract][Full Text] [Related]
16. Comparative pharmacokinetics of acetyl salicylic acid and its metabolites in children suffering from autoimmune diseases. Juárez Olguín H; Flores Pérez J; Lares Asseff I; Loredo Abdalá A; Carbajal Rodríguez L Biopharm Drug Dispos; 2004 Jan; 25(1):1-7. PubMed ID: 14716747 [TBL] [Abstract][Full Text] [Related]
17. Semi-physiologic model validation and bioequivalence trials simulation to select the best analyte for acetylsalicylic acid. Cuesta-Gragera A; Navarro-Fontestad C; Mangas-Sanjuan V; González-Álvarez I; García-Arieta A; Trocóniz IF; Casabó VG; Bermejo M Eur J Pharm Sci; 2015 Jul; 74():86-94. PubMed ID: 25869458 [TBL] [Abstract][Full Text] [Related]
18. Interactions between CYP2C9 and UGT1A6 polymorphisms and nonsteroidal anti-inflammatory drugs in colorectal cancer prevention. Samowitz WS; Wolff RK; Curtin K; Sweeney C; Ma KN; Andersen K; Levin TR; Slattery ML Clin Gastroenterol Hepatol; 2006 Jul; 4(7):894-901. PubMed ID: 16797247 [TBL] [Abstract][Full Text] [Related]
19. Effect of the UGT2B15 genotype on the pharmacokinetics, pharmacodynamics, and drug interactions of intravenous lorazepam in healthy volunteers. Chung JY; Cho JY; Yu KS; Kim JR; Jung HR; Lim KS; Jang IJ; Shin SG Clin Pharmacol Ther; 2005 Jun; 77(6):486-94. PubMed ID: 15961980 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic interaction study of a fixed combination of 500 mg acetylsalicylic acid/30 mg pseudoephedrine versus each of the single active ingredients in healthy male volunteers. Lücker PW; Birkel M; Hey B; Loose I; Schaefer A Arzneimittelforschung; 2003; 53(4):260-5. PubMed ID: 12785122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]